Kallikrein-related peptidase 4 (KLK4) mRNA predicts short-term relapse in colorectal adenocarcinoma patients - Kontos, C.K.; Chantzis, D.; Papadopoulos, I.N.; Scorilas, A. (Cancer Letters, 2013)